|
[Related PubMed/MEDLINE]
Total Number of Papers: 143
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: F. nucleatum |
| Long Form |
: Fusobacterium nucleatum |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Colonization of Fusobacterium nucleatum is an independent predictor of poor prognosis in gastric cancer patients with venous thromboembolism: a retrospective cohort study. |
GC, HR, PLR, VTE |
| 2 |
2023 |
Virulence Factors of the Periodontal Pathogens: Tools to Evade the Host Immune Response and Promote Carcinogenesis. |
A. actinomycetemcomitans, P. gingivalis |
| 3 |
2022 |
A case report of severe Fusobacterium nucleatum sepsis secondary to nephrectomy. |
--- |
| 4 |
2022 |
A positive feed-forward loop between Fusobacterium nucleatum and ethanol metabolism reprogramming drives laryngeal cancer progression and metastasis. |
ADH1B, LSCC, TGFBR2 |
| 5 |
2022 |
An injectable multifunctional thermo-sensitive chitosan-based hydrogel for periodontitis therapy. |
P. gingivalis, ROS, S. gordonii |
| 6 |
2022 |
Antibiofilm activity of ultra-small gold nanoclusters against Fusobacterium nucleatum in dental plaque biofilms. |
--- |
| 7 |
2022 |
Antimicrobial behavior of titanium coating with chlorhexidine-doped thin film exposed to a biofilm supplemented with nicotine. |
--- |
| 8 |
2022 |
Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach. |
H. pylori, M. hyorhinis |
| 9 |
2022 |
Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis. |
CRC, DFS, FFPE, MSI, ROC |
| 10 |
2022 |
Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis. |
5-FU, CRC, DOR, NLR, PLR |
| 11 |
2022 |
Effect of gut microbiota in the colorectal cancer and potential target therapy. |
CRC, ETBF, S. bovis |
| 12 |
2022 |
Evaluating the predictive performance of gut microbiota for the early-stage colorectal cancer. |
AUCs, CRC, CrI, LCMs, S. bovis |
| 13 |
2022 |
Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. |
DAI, DSS, IECs, TNF-alpha, UC |
| 14 |
2022 |
Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. |
--- |
| 15 |
2022 |
Fusobacterium nucleatum and Malignant Tumors of the Digestive Tract: A Mechanistic Overview. |
--- |
| 16 |
2022 |
Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck. |
dMMR, HNSCC, MMR, MSI |
| 17 |
2022 |
Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. |
CRC |
| 18 |
2022 |
Fusobacterium nucleatum load in MSI colorectal cancer subtypes. |
CRC, MSI, MSS |
| 19 |
2022 |
Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model. |
AOM/DSS, CRC |
| 20 |
2022 |
Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-kappaB/ICAM1 axis. |
CRC |
| 21 |
2022 |
Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. |
CRC, NK, Th17 |
| 22 |
2022 |
Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway. |
ALF |
| 23 |
2022 |
Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis. |
CRC, FOXD3, KIF26B, PDX |
| 24 |
2022 |
Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer. |
CRC |
| 25 |
2022 |
Fusobacterium nucleatum Subspecies Differ in Biofilm Forming Ability in vitro. |
CV |
| 26 |
2022 |
Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis. |
AP, F. nucleatum-EVs, GSDME, PANoptosis, ZBP1 |
| 27 |
2022 |
Fusobacterium nucleatum: The Opportunistic Pathogen of Periodontal and Peri-Implant Diseases. |
--- |
| 28 |
2022 |
Graphene Coated Ti-6Al-4V Exhibits Antibacterial and Antifungal Properties Against Oral Pathogens. |
C. albicans, P. gingivalis, ROS, SEM |
| 29 |
2022 |
Interactions Between Streptococcus gordonii and Fusobacterium nucleatum Altered Bacterial Transcriptional Profiling and Attenuated the Immune Responses of Macrophages. |
S. gordonii |
| 30 |
2022 |
Investigation of Fusobacterium Nucleatum in saliva and colorectal mucosa: a pilot study. |
CRN |
| 31 |
2022 |
Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review. |
CRC, EMT |
| 32 |
2022 |
Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. |
CRC, EMT, lncRNA, YBX1 |
| 33 |
2022 |
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences. |
AA, CA, CRC |
| 34 |
2022 |
Neutrophil Transcriptional Deregulation by the Periodontal Pathogen Fusobacterium nucleatum in Gastric Cancer: A Bioinformatic Study. |
CCGD, DEGs, GO, PPI |
| 35 |
2022 |
Outer Membrane Vesicles From Fusobacterium nucleatum Switch M0-Like Macrophages Toward the M1 Phenotype to Destroy Periodontal Tissues in Mice. |
BMDMs, LDH, MGFs, OMVs, TRAP |
| 36 |
2022 |
Pathogenic Mechanisms of Fusobacterium nucleatum on Oral Epithelial Cells. |
PAMPs, PRRs |
| 37 |
2022 |
Safe-by-Design Antibacterial Peroxide-Substituted Biomimetic Apatites: Proof of Concept in Tropical Dentistry. |
A. actinomycetemcomitans, P. gingivalis |
| 38 |
2022 |
Soybean peptide inhibits the biofilm of periodontopathic bacteria via bactericidal activity. |
MBC, MIC, P. gingivalis, PI, S. mitis |
| 39 |
2022 |
The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions. |
DCs, E. coli, F. varium, L. bulgaricus, MFI |
| 40 |
2022 |
Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells. |
--- |
| 41 |
2022 |
Vanillin Derivatives Reverse Fusobacterium nucleatum-Induced Proliferation and Migration of Colorectal Cancer Through E-Cadherin/beta-Catenin Pathway. |
CRC |
| 42 |
2021 |
ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer. |
ANGPTL4 |
| 43 |
2021 |
Anti-Early Stage of Bacterial Recolonization Effect of Curcuma longa Extract as Photodynamic Adjunctive Treatment. |
LEDs, P. intermedia, PCR, PDT, SRP |
| 44 |
2021 |
Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. |
CRC |
| 45 |
2021 |
Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment. |
CI, MSI, TAM |
| 46 |
2021 |
Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma. |
ESCC |
| 47 |
2021 |
Detection of Fusobacterium nucleatum subspecies in the saliva of pre-colorectal cancer patients, using tandem mass spectrometry. |
CRA, CRC |
| 48 |
2021 |
Effect of Theaflavin on Oral Bacteria in Japanese Subjects: A Randomized, Placebo-Controlled, Double-Blind Study. |
P. gingivalis, TFs |
| 49 |
2021 |
Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes. |
CRC, CRP, ESR, HC, IBS-D, PCR, UC, WBC |
| 50 |
2021 |
Fusobacterium nucleatum - Friend or foe? |
--- |
| 51 |
2021 |
Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. |
CRC, TME |
| 52 |
2021 |
Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients. |
H. pylori |
| 53 |
2021 |
Fusobacterium nucleatum Promotes Cisplatin-Resistance and Migration of Oral Squamous Carcinoma Cells by Up-Regulating Wnt5a-Mediated NFATc3 Expression. |
NFATc3 |
| 54 |
2021 |
Gene expression profiles of mitochondria-endoplasmic reticulum tethering in human gingival fibroblasts in response to periodontal pathogens. |
GRP75, IER3, Mfn1, P. gingivalis, PINK1, SIGMAR1, TNF-alpha |
| 55 |
2021 |
Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells. |
CRC, IHC, NK, PBS |
| 56 |
2021 |
Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. |
A. muciniphila, H. hepaticus, L. reuteri, NK cells, TME |
| 57 |
2021 |
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis. |
CI |
| 58 |
2021 |
One gut microbiota, Fusobacterium nucleatum aggravates Neonatal necrotizing enterocolitis by induction of IRF5 expression through lncRNA ENO1-IT1/miR-22-3p axis. |
NEC |
| 59 |
2021 |
Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA. |
OMVs, P. gingivalis |
| 60 |
2021 |
Prediagnostic Antibody Responses to Fusobacterium nucleatum Proteins Are Not Associated with Risk of Colorectal Cancer in a Large U.S. Consortium. |
--- |
| 61 |
2021 |
Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells. |
APOs, BMDMs, hDSCs, NO, NOD, RIPK2, WT |
| 62 |
2021 |
The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. |
CAP, CRC, ROC |
| 63 |
2020 |
Brain abscess in a patient with psoriatic arthritis treated with adalimumab: A case report. |
MRI, P. micra, S. sanguinis |
| 64 |
2020 |
Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy. |
ELISA, G. adiacens, HGD, IPMNs, S. gordonii |
| 65 |
2020 |
Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis. |
CRC, OR, PROSPERO |
| 66 |
2020 |
Efficacy of antimicrobial photodynamic and photobiomodulation therapy against Treponema denticola, fusobacterium nucleatum and human beta defensin-2 levels in patients with gingivitis undergoing fixed orthodontic treatment: A clinic-laboratory study. |
aPDT, FMPS, GCF, hBD, PBM, PD, T. denticola, US |
| 67 |
2020 |
First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening. |
E. coli, F. prausnitzii, FIT |
| 68 |
2020 |
Fusobacterium nucleatum Activates Endoplasmic Reticulum Stress to Promote Crohn's Disease Development via the Upregulation of CARD3 Expression. |
CARD3, CD, ERS |
| 69 |
2020 |
Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner. |
IBS, IBS-D, MS |
| 70 |
2020 |
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma. |
ESCC |
| 71 |
2020 |
Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation. |
DSS, IBD, IL |
| 72 |
2020 |
Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients. |
CRC, GC |
| 73 |
2020 |
Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression. |
AOM, CQ, CRC, DSS |
| 74 |
2020 |
Fusobacterium nucleatum Promotes the Development of Ulcerative Colitis by Inducing the Autophagic Cell Death of Intestinal Epithelial. |
3-MA, CQ, IEC, LPS, UC |
| 75 |
2020 |
Immune induction identified by TMT proteomics analysis in Fusobacterium nucleatum autoinducer-2 treated macrophages. |
AI-2, PAAD, QS, TNFSF9 |
| 76 |
2020 |
Inhibitory Effect of a KSL-W Peptide-Loaded Poloxamer 407-Based Microemulsions for Buccal Delivery on Fusobacterium nucleatum Biofilm. |
CLX, PLM, SAXS |
| 77 |
2020 |
Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection. |
BMSCs |
| 78 |
2020 |
Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis. |
CRC, IBD, iHMP, LDA |
| 79 |
2020 |
Persistent Exposure to Fusobacterium nucleatum Triggers Chemokine/Cytokine Release and Inhibits the Proliferation and Osteogenic Differentiation Capabilities of Human Gingiva-Derived Mesenchymal Stem Cells. |
ALP, DEGs, GMSCs |
| 80 |
2020 |
The Pathogenic Effects of Fusobacterium nucleatum on the Proliferation, Osteogenic Differentiation, and Transcriptome of Osteoblasts. |
DEGs, STEM |
| 81 |
2020 |
The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management. |
CRC, miRNA, TLR2, TLR4 |
| 82 |
2019 |
Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum. |
CRC, CREBBP |
| 83 |
2019 |
Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer. |
CI, EPIC, ORs |
| 84 |
2019 |
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. |
BECN1, PCR |
| 85 |
2019 |
Autoinducer-2 of Fusobacterium nucleatum promotes macrophage M1 polarization via TNFSF9/IL-1beta signaling. |
AI-2, CRC |
| 86 |
2019 |
Effect of the aging of titanium and zirconia abutment surfaces on the viability, adhesion, and proliferation of cells and the adhesion of microorganisms. |
NOK-si, P. gingivalis, S. sanguinis, SEM, Ti |
| 87 |
2019 |
Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity. |
CRC |
| 88 |
2019 |
Fusobacterium nucleatum Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT/MAPK and NF-kappaB Signaling Pathways in Human Gingival Fibroblasts. |
GFs, ROS |
| 89 |
2019 |
Fusobacterium nucleatum stimulates monocyte adhesion to and transmigration through endothelial cells. |
ECs, HUVECs, IL |
| 90 |
2019 |
Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. |
CRC, NK |
| 91 |
2019 |
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. |
CRC, HR |
| 92 |
2019 |
Immunological Pathways Triggered by Porphyromonas gingivalis and Fusobacterium nucleatum: Therapeutic Possibilities? |
P. gingivalis |
| 93 |
2019 |
Improved antibacterial effects of alkali-transformed saponin from quinoa husks against halitosis-related bacteria. |
ATS, C. perfringens, P. gingivalis, QS |
| 94 |
2019 |
Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. |
ESCC, PET/CT, RECISTs, RFS, TRG |
| 95 |
2019 |
Microbiome Dysbiosis and Predominant Bacterial Species as Human Cancer Biomarkers. |
CRC, G. adiacens, H. pylori, LC, P. gingivalis |
| 96 |
2019 |
Novel nanotechnology and near-infrared photodynamic therapy to kill periodontitis-related biofilm pathogens and protect the periodontium. |
aPDT, CFU, NIR, P. gingivalis, S. sanguinis, UV |
| 97 |
2019 |
Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers. |
CI, CRC, MSI, OR |
| 98 |
2019 |
Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis. |
CRA, CRC, miRNAs, MSI, qPCR |
| 99 |
2019 |
Serum Levels of Interleukin-6 and Titers of Antibodies Against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma. |
ELISA, IL-6, OSCC, P. gingivalis |
| 100 |
2019 |
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy. |
CRC |
|
A Search Service for Abbreviation / Long Form
